Alto Neuroscience
Clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform. Learn more
Launch date
Employees
Market cap
$324m
Enterprise valuation
$140m (Public information from Sep 2024)
Share price
$12.1 ANRO
Los Altos California (HQ)
Authorizing premium user...